RISS 학술연구정보서비스

검색

인기 검색어

    다국어 입력

    http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

    변환된 중국어를 복사하여 사용하시면 됩니다.

    예시)
    • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
    • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
    닫기
    KCI등재

    새로운 임신 기술과 '위험', 그리고 아픈 아이들  :  보조생식술 결과의 국제비교를 중심으로 = New Reproductive Technologies, 'Risks', and Unhealthy Children : International Comparison of ART Results Reports

    한글로보기

    https://www.riss.kr/link?id=A60170631

    • 0

      상세조회
    • 0

      다운로드
    서지정보 열기
    • 내보내기
    • 내책장담기
    • 공유하기
      • URL 복사
    • 오류접수
    인용문이 복사되었습니다.

    부가정보

    국문 초록 (Abstract) kakao i 다국어 번역

    이 논문은 새로운 임신 기술이 수반하는 '위험'에 대해, 특히 체외수정(IVF) 기술로 태어난 아이들 건강 조사 연구를 중심으로 살펴본다. 흔히 시험관아기로 불리는 이 기술은 불임부부에게 자신의 아이를 가질 수 있는 희망을 준 기술로 찬사를 받았고 전 세계에 널리 확산 되었다. 그런데 이로부터 태어난 아이들의 건강에 대한 우려가 유럽과 북미를 중심으로 제기 되었다. 이러한 우려는 아이들에 대한 추적조사 자료와 함께 실증적으로 제기되었고, 이에 대한 대책으로 체외수정 시술에서 한 번에 이식하는 배아의 수에 대한 규제가 이루어졌다. 그런데 한국을 비롯하여 아시아 국가에서는 이러한 추적조사가 거의 이루어진 바 없고 한번에 이식하는 배아의 수도 그동안 별 변화가 없었다. 이와 함께 전체 출생 인구에서 다태아가 차지하는 비율은 급격히 증가하고 있다. 또 다른 한편, 전 세계적으로도 아이들에 대한연구는 많이 이루어진 반면 이 기술이 여성에 미치는 영향에 대해서는 소수의 연구가 있을뿐이다. 이러한 점에서 이 기술 '위험'의 인지와 대책 마련에서 지구적 불균등을, '위험' 문제구성에서 성별 정치의 일면을 읽을 수 있다. 또한 무엇이 '위험'으로 간주되고 어떤 대책이 마련되는가를 보면 기술 위험의 사회적 구성 또한 발견할 수 있다.
    번역하기

    이 논문은 새로운 임신 기술이 수반하는 '위험'에 대해, 특히 체외수정(IVF) 기술로 태어난 아이들 건강 조사 연구를 중심으로 살펴본다. 흔히 시험관아기로 불리는 이 기술은 불임부부에게 ...

    이 논문은 새로운 임신 기술이 수반하는 '위험'에 대해, 특히 체외수정(IVF) 기술로 태어난 아이들 건강 조사 연구를 중심으로 살펴본다. 흔히 시험관아기로 불리는 이 기술은 불임부부에게 자신의 아이를 가질 수 있는 희망을 준 기술로 찬사를 받았고 전 세계에 널리 확산 되었다. 그런데 이로부터 태어난 아이들의 건강에 대한 우려가 유럽과 북미를 중심으로 제기 되었다. 이러한 우려는 아이들에 대한 추적조사 자료와 함께 실증적으로 제기되었고, 이에 대한 대책으로 체외수정 시술에서 한 번에 이식하는 배아의 수에 대한 규제가 이루어졌다. 그런데 한국을 비롯하여 아시아 국가에서는 이러한 추적조사가 거의 이루어진 바 없고 한번에 이식하는 배아의 수도 그동안 별 변화가 없었다. 이와 함께 전체 출생 인구에서 다태아가 차지하는 비율은 급격히 증가하고 있다. 또 다른 한편, 전 세계적으로도 아이들에 대한연구는 많이 이루어진 반면 이 기술이 여성에 미치는 영향에 대해서는 소수의 연구가 있을뿐이다. 이러한 점에서 이 기술 '위험'의 인지와 대책 마련에서 지구적 불균등을, '위험' 문제구성에서 성별 정치의 일면을 읽을 수 있다. 또한 무엇이 '위험'으로 간주되고 어떤 대책이 마련되는가를 보면 기술 위험의 사회적 구성 또한 발견할 수 있다.

    더보기

    다국어 초록 (Multilingual Abstract) kakao i 다국어 번역

    This paper intends to study the risks of technology, particularly in terms of the health outcome surveys and follow-up of children born through IVF (in vitro fertilization, also known more colloquially as test-tube babies). From the early stage of IVF's development, the disabilities of children born through IVF was the key target for risk management practices, and the follow-up studies of the children born through IVF have been working through samples or complete enumeration surveys in mostly European countries. The results showed that the overall health outcomes of IVF children were relatively poorer than for other children, and the multiple pregnancies and births from multiple embryo implantations was pointed out as the main cause for this. Such an analysis result was followed by legislative or administrative regulation of the number of embryos allowed to be transferred in actual IVF practice. Risk management status differs from country to country. Since the first 'test tube baby' was born in Korea in 1985, 235,000 cases were accumulated between 1992, when official reporting began, and 2007. However, no follow-up study of the children has been conducted nor has the official regulation of the number of embryos been transferred along with the technology. Even today, the rate of transferring 4 or more embryos in an IVF procedure is more than 50% in Korea, and the ratio of multiple-births to the total number of babies born began rapidly increasing in the 2000's. I suggest that the risk of technology should be considered not just as a side effect of technological development but as an essential part of those processes. Furthermore, the social construction of the risks, which considers risk according to the locality's status of technological development, can also be observed.
    번역하기

    This paper intends to study the risks of technology, particularly in terms of the health outcome surveys and follow-up of children born through IVF (in vitro fertilization, also known more colloquially as test-tube babies). From the early stage of IVF...

    This paper intends to study the risks of technology, particularly in terms of the health outcome surveys and follow-up of children born through IVF (in vitro fertilization, also known more colloquially as test-tube babies). From the early stage of IVF's development, the disabilities of children born through IVF was the key target for risk management practices, and the follow-up studies of the children born through IVF have been working through samples or complete enumeration surveys in mostly European countries. The results showed that the overall health outcomes of IVF children were relatively poorer than for other children, and the multiple pregnancies and births from multiple embryo implantations was pointed out as the main cause for this. Such an analysis result was followed by legislative or administrative regulation of the number of embryos allowed to be transferred in actual IVF practice. Risk management status differs from country to country. Since the first 'test tube baby' was born in Korea in 1985, 235,000 cases were accumulated between 1992, when official reporting began, and 2007. However, no follow-up study of the children has been conducted nor has the official regulation of the number of embryos been transferred along with the technology. Even today, the rate of transferring 4 or more embryos in an IVF procedure is more than 50% in Korea, and the ratio of multiple-births to the total number of babies born began rapidly increasing in the 2000's. I suggest that the risk of technology should be considered not just as a side effect of technological development but as an essential part of those processes. Furthermore, the social construction of the risks, which considers risk according to the locality's status of technological development, can also be observed.

    더보기

    목차 (Table of Contents)

    • 국문초록
    • Ⅰ. 들어가며
    • Ⅱ. 기존 연구 및 이론적 배경
    • Ⅲ. '위험'에 대한 인지와 조사 보고
    • Ⅲ. '위험'에 대한 대처
    • 국문초록
    • Ⅰ. 들어가며
    • Ⅱ. 기존 연구 및 이론적 배경
    • Ⅲ. '위험'에 대한 인지와 조사 보고
    • Ⅲ. '위험'에 대한 대처
    • Ⅳ. 기술 '위험' 관리의 지구적 불균등
    • Ⅴ. 기술 '위험'의 성별 정치
    • Ⅵ. 나오며
    • 참고문헌
    • Abstract
    더보기

    참고문헌 (Reference)

    1 하정옥, "한국 생명의료기술의 전환에 관한 연구 : 재생산기술로부터 생명공학기술로" 서울대학교 대학원 2006

    2 하정옥, "한국 생명의료기술의 사회적 관리 미비와 재생산의 비가시화: 체외수정기술 자료 구성의 국제 비교를 중심으로" 한국여성연구원 23 (23): 141-188, 2006

    3 OECD 대한민국 정책센터 사회정책본부, "한 눈에 보는 OECD 보건지표 2009" 2010

    4 대한산부인과학회 인공수태시술의료기관 심사소위원회, "조사보고서 - 한국보조생식술의 현황: 1994년" 41 (41): 236-252, 1998

    5 이혜정, "우리나라 모자보건 정책사업 분석 - 미숙아와 저체중출생아를 중심으로 -" 아동간호학회 15 (15): 81-87, 2009

    6 하정옥, "생명의료기술의 사회학: 체외수정기술 논의를 중심으로" 서울대학교 여성연구소 2004

    7 대한산부인과학회 보조생식술소위원회, "사보고서 - 한국보조생식술의 현황:2007년" 53 (53): 1052-1077, 2010

    8 대한산부인과학회 보조생식술소위원회, "사보고서 - 한국보조생식술의 현황:2006년" 52 (52): 1212-1238, 2009

    9 대한산부인과학회 보조생식술소위원회, "사보고서 - 한국보조생식술의 현황:2005년" 51 (51): 1421-1447, 2008

    10 대한산부인과학회 인공수태시술의료기관 심사소위원회, "사보고서 - 한국보조생식술의 현황:2004년" 50 (50): 1615-1639, 2007

    1 하정옥, "한국 생명의료기술의 전환에 관한 연구 : 재생산기술로부터 생명공학기술로" 서울대학교 대학원 2006

    2 하정옥, "한국 생명의료기술의 사회적 관리 미비와 재생산의 비가시화: 체외수정기술 자료 구성의 국제 비교를 중심으로" 한국여성연구원 23 (23): 141-188, 2006

    3 OECD 대한민국 정책센터 사회정책본부, "한 눈에 보는 OECD 보건지표 2009" 2010

    4 대한산부인과학회 인공수태시술의료기관 심사소위원회, "조사보고서 - 한국보조생식술의 현황: 1994년" 41 (41): 236-252, 1998

    5 이혜정, "우리나라 모자보건 정책사업 분석 - 미숙아와 저체중출생아를 중심으로 -" 아동간호학회 15 (15): 81-87, 2009

    6 하정옥, "생명의료기술의 사회학: 체외수정기술 논의를 중심으로" 서울대학교 여성연구소 2004

    7 대한산부인과학회 보조생식술소위원회, "사보고서 - 한국보조생식술의 현황:2007년" 53 (53): 1052-1077, 2010

    8 대한산부인과학회 보조생식술소위원회, "사보고서 - 한국보조생식술의 현황:2006년" 52 (52): 1212-1238, 2009

    9 대한산부인과학회 보조생식술소위원회, "사보고서 - 한국보조생식술의 현황:2005년" 51 (51): 1421-1447, 2008

    10 대한산부인과학회 인공수태시술의료기관 심사소위원회, "사보고서 - 한국보조생식술의 현황:2004년" 50 (50): 1615-1639, 2007

    11 대한산부인과학회 인공수태시술의료기관 심사소위원회, "사보고서 - 한국보조생식술의 현황:2003년" 49 (49): 2480-2497, 2006

    12 대한산부인과학회 인공수태시술의료기관 심사소위원회, "사보고서 - 한국보조생식술의 현황:2002년" 48 (48): 2777-2796, 2005

    13 대한산부인과학회 인공수태시술의료기관 심사소위원회, "사보고서 - 한국보조생식술의 현황:2001년" 47 (47): 2285-2302, 2004

    14 대한산부인과학회 인공수태시술의료기관 심사소위원회, "사보고서 - 한국보조생식술의 현황:2000" 46 (46): 1888-1904, 2003

    15 대한산부인과학회 인공수태시술의료기관 심사소위원회, "사보고서 - 한국보조생식술의 현황:1999년" 45 (45): 1700-1717, 2002

    16 대한산부인과학회 인공수태시술의료기관 심사소위원회, "사보고서 - 한국보조생식술의 현황:1998년" 44 (44): 1883-1899, 2001

    17 대한산부인과학회 인공수태시술의료기관 심사소위원회, "사보고서 - 한국보조생식술의 현황:1997년" 42 (42): 2151-2175, 1999

    18 대한산부인과학회 인공수태시술의료기관 심사소위원회, "사보고서 - 한국보조생식술의 현황:1996년" 42 (42): 231-253, 1999

    19 대한산부인과학회 인공수태시술의료기관 심사소위원회, "사보고서 - 한국보조생식술의 현황:1995년" 42 (42): 681-703, 1999

    20 최영민, "불임부부지원사업 보고: 2006년" 대한산부인과학회 2007

    21 대한산부인과학회 인공수태시술의료기관 심사소위원회, "대한산부인과학회 보조생식술 윤리지침"

    22 Saldeen, P., "Would Legislation Imposing Single ET Be a Feasible Way to Reduce the Rate of Multiple Pregnancies after IVF Treatment?" 20 (20): 4-8, 2005

    23 G. D. Adamson, "World Collaborative Report on IVF, 2000" 85 (85): 1586-1622, 2000

    24 de Mouzon, J., "World Collaborative Report on IVF Preliminary Data for 1995" 14 (14): 251S-265S, 1997

    25 J. de Mouzon, "World Collaborative Report on ART, 2002" 24 (24): 2310-2320, 2002

    26 D. Adamson, "World Collaborative Report on ART, 1998" 209-219, 2002

    27 Min, J. K., "What Is the Most Relevant Standard of Success in Assisted Reproduction? The Singleton, Term Gestation, Live Birth Rate per Cycle Initiated: The BESST Endpoint for Assisted Reproduction" 19 (19): 3-7, 2004

    28 Foresta, C., "Warning Note on Male Infertility Treatment" 347 (347): 618-, 1996

    29 Foresta, C., "Use of ICSI in Severe Male Factor Infertility" 348 (348): 59-, 1996

    30 Nyboe Andersen, A., "Trends in the Use of Intracytoplasmatic Sperm Injection Marked Variability between Countries" 14 (14): 593-604, 2008

    31 Klein, R. D., "The Ultimate Colonisation: Reproductive and Genetic Engineering" Attic Press 1992

    32 Nygren, K., "The Swedish Experience of ARTs Surveillance, In Current Practices and Controversies in Assisted Reproduction (: Report of a Meeting on “Medical, Ethical and Social Aspects of Assisted Reproduction" World Health Organization 351-354, 2002

    33 Msall, M. E., "The Spectrum of Behavioral Outcomes after Extreme Prematurity: Regulatory, Attention, Social, and Adaptive Dimensions" 32 (32): 42-50, 2008

    34 Voluntary Licensing Authority for Human In Vitro Fertilisation and Embryology (Medical Research Council/Royal College of Obstetricians and Gynaecologists, "The Second Report of the Voluntary Licensing Authority for Human In Vitro Fertilisation and Embryology" VLA 1987

    35 Dickey, R. P., "The Relative Contribution of ARTs and Ovulation Induction to Multiple births in the United States 5 Years after the Society for ART/American Society for Reproductive Medicine Recommendation to Limit the NET" 88 (88): 1554-1561, 2007

    36 Barker, D. J. P., "The Origins of the Developmental Origins Theory" 261 (261): 412-417, 2007

    37 Wang, J. X., "The Obstetric Outcome of Singleton Pregnancies Following IVF/gamete intra-Fallopian transfer" 9 (9): 141-146, 1994

    38 Voluntary Licensing Authority for Human In Vitro Fertilisation and Embryology (Medical Research Council/Royal College of Obstetricians and Gynaecologists, "The First Report of the Voluntary Licensing Authority for Human In Vitro Fertilisation and Embryology" VLA 1986

    39 Wang, J. X., "The Effect of Various Infertility Treatments on the Risk of Preterm Birth" 17 (17): 945-949, 2002

    40 Barlow, D. H., "The Debate on Single ET in IVF. How Will Today’s Arguments Be Viewed from the Perspective of 2020?" 20 (20): 1-3, 2005

    41 Human Fertilisation and Embryology Authority, "Tenth Annual Report and Accounts 2001" HFEA 2002

    42 Brown, D., "Studies: Test-Tube Babies Face Higher Health Risks"

    43 Fishel, S., "Should ICSI Be the Treatment of Choice for All Cases of In-Vitro Conception" 15 (15): 1278-1283, 2000

    44 Ramsey, P., "Shall We ‘Reproduce’?: II. Rejoinders and Future Forecast" 220 (220): 1480-1485, 1972

    45 Ramsey, P., "Shall We ‘Reproduce’?: I. The Medical Ethics of IVF" 220 (220): 1346-1350, 1972

    46 Hervé, C., "Sex Chromosome Abnormalities After ICSI" 346 (346): 1096-1097, 1995

    47 Liebaers, I., "Sex Chromosome Abnormalities After ICSI" 346 (346): 1095-, 1995

    48 In't Veld, P., "Sex Chromosomal Abnormalities and ICSI" 346 (346): 773-, 1995

    49 Barber, B., "Public Awareness and Government Regulation of Research on IVF in Humans, In HEW Support of Research Involving Human IVF and ET, by the Ethics Advisory Board of the Department of Health, Education and Welfare" US Government Printing Office 1979

    50 Bonduelle, M., "Prospective Follow-Up Study of 423 Children Born After ICSI" 11 (11): 1558-1564, 1996

    51 Bonduelle, M., "Prenatal Testing in ICSI Pregnancies: Incidence of Chromosomal Anomalies in 1586 Karyotypes and Relation to Sperm Parameters" 17 (17): 2600-2614, 2002

    52 Palermo, G., "Pregnancies After Intracytoplasmic Injection of Single Spermatozoon into an Oocyte" 340 (340): 17-18, 1992

    53 Bae, J., "Plan of Increasing Medical Support for Premature Babies and Unhealthy Infants" Management Center for Health Promotion 2007

    54 Olivennes, F., "Perinatal Outcome and Developmental Studies on Children BornAfter IVF" 8 (8): 117-128, 2002

    55 Skakkebk, N. E., "Pathogenesis and Management of Male Infertility" 343 (343): 1473-1479, 1994

    56 Halliday, J., "Outcomes of IVF Conceptions: Are They Different?" 21 (21): 67-81, 2007

    57 Sutcliffe, A. G., "Outcome in the Second Year of Life after IVF by ICSI: A UK Case-Control Study" 357 (357): 2080-2084, 2001

    58 Koudstaal, J., "Obstetric Outcome of Twin Pregnancies after In-Vitro Fertilization: A Matched Control Study in Four Dutch University Hospitals" 15 (15): 935-940, 2000

    59 Koudstaal, J., "Obstetric Outcome of Singleton Pregnancies after IVF: A Matched Control Study in Four Dutch University Hospitals" 15 (15): 1819-1825, 2000

    60 Craft, I., "Multiple Pregnancy and Assisted Reproduction" (8560) : 692-692, 1987

    61 Jones, H. W., "Multiple Pregnancies: A Call for Action" 75 (75): 11-13, 2001

    62 Ombelet, W., "Multiple Gestation and Infertility Treatment: Registration, Reflection and Reaction ―The Belgian Project" 11 (11): 3-14, 2005

    63 Jadva, V., "Mom by Choice, Single by Life's Circumstance ...’ Findings from a Large Scale Survey of the Experiences of Single Mothers by Choice" 12 (12): 175-184, 2009

    64 Kremer, J. A. M., "Microdeletions of the Y Chromosome and ICSI: From Gene to Clinic" 12 (12): 687-691, 1997

    65 Bowen, J. R., "Medical and Developmental Outcome at 1 Year for Children Conceived by ICSI" 351 (351): 1529-1534, 1998

    66 Tallo, C. P., "Maternal and Neonatal Morbidity Associated with IVF" 127 (127): 794-800, 1995

    67 Corea, G., "Man-Made Women: How New Reproductive Technologies Affect Women" Hutchinson 1985

    68 Spallone, P, "Made to Order: The Myth of Reproductive and Genetic Progress" Pergamon Press 1987

    69 Wilson, C. L., "Looking Downstream: a Review of the Literature on Physical andPsychosocial Health Outcomes in Adolescents and Young Adults WhoWere Conceived by ART" 26 (26): 1209-1219, 2011

    70 Schieve, L. A., "Live-Birth Rates and Multiple-Birth Risk Using IVF" 282 (282): 1832-1838, 1999

    71 Craft, I., "Licensing Work on IVF and Related Procedures" I (I): 1373-, 1987

    72 Anderson, D. C., "Licensing Work on IVF and Related Procedures" I (I): 1373-, 1987

    73 Richards, M., "Licensing Work on IVF and Related Procedures" I : 1373-1374, 1987

    74 van Balen, F., "Interpreting Infertility: A View from the Social Sciences, In Infertility around the Globe: New Thinking on Childlessness, Gender, and Reproductive Technologies" University of California Press 3-32, 2002

    75 Nygren, K., "International Registries of ARTs, In Current Practices and Controversies in Assisted Reproduction (: Report of a Meeting on “Medical, Ethical and Social Aspects of Assisted Reproduction" World Health Organization 377-380, 2002

    76 Nygren, K. G., "International Committee for Monitoring ART (ICMART) World Report: ART 2003" 95 (95): 2209-2222, 2011

    77 Halliday, J., "Increased Risk of Blastogenesis Birth Defects, Arising in the First4 Weeks of Pregnancy, after ARTs" 25 (25): 59-65, 2010

    78 Kerin, J. F., "Incidence of Multiple Pregnancy after IVT and ET" II (II): 537-540, 1983

    79 Philipp, E. E., "Impact of the Human Fertilisation and Embryology Act (1990) on the Practice of Reproductive Medicine in the United Kingdom" 59 (59): 285-287, 1993

    80 Wisborg, K., "IVF and Preterm Delivery, Low Birth Weight, and Admission to the Neonatal Intensive Care Unit: a Prospective Follow-Up Study" 94 (94): 2102-2106, 2010

    81 Kalra, S. K.,l, "IVF and Adverse Childhood Outcomes: What We Know, Where We Are Going, and How We Will Get There. A Glimpse into What Lies behind and Beckons ahead" 95 (95): 1887-1889, 2011

    82 Tournaye, H., "ICSI: A Technique Too Far?" 26 (26): 63-69, 2003

    83 Tripp, B. M., "ICSI and Potential Transmission of Genetic Disease" 277 (277): 963-964, 1997

    84 Van Steirteghem, A. C., "Higher Success Rate by ICSI than by Subzonal Insemination. Report of a Second Series of 300 Consecutive Treatment Cycles" 1055-1060, 1993

    85 Levene, M. I., "Higher Multiple Births and the Modern Management of Infertility in Britain: For the British Association of Perinatal Medicine" 99 (99): 607-613, 1992

    86 Australian In Vitro Fertilisation Collaborative Group, "High Incidence of Preterm Births and Early Losses in Pregnancy after IVF" 291 (291): 1160-1163, 1985

    87 Van Steirteghem, A. C., "High Fertilization and Implantation Rate After ICSI" 8 (8): 1061-1066, 1993

    88 The Practice Committee of the Society for Assisted Reproductive Technology and the American Society for Reproductive Medicine, "Guidelines on the NET" 82 (82): 773-774, 2004

    89 The Practice Committee of the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology, "Guidelines on NET" 92 (92): 1518-1519, 2009

    90 Voluntary Licensing Authority for Human In Vitro Fertilisation and Embryology (Medical Research Council/Royal College of Obstetricians and Gynaecologists), "Guidelines for Both Clinical and Research Application of Human In Vitro Fertilisation" VLA 1985

    91 Morris, R. S., "Genetic Abnormalities, Male Infertility, and ICSI" 347 (347): 1277-, 1996

    92 Leunens, L., "Follow-Up of Cognitive and Motor Development of 10-Year-Old Singleton Children Born after ICSI Compared with Spontaneously Conceived Children" 23 (23): 105-111, 2008

    93 Miles, H. L., "Fetal Origins of Adult Disease: A Paediatric Perspective" 6 (6): 261-268, 2005

    94 Evers, J. L. H., "Female Subfertility" 360 (360): 151-159, 2002

    95 Goldenberg, R. L, "Epidemiology and Causes of Preterm Birth" 371 (371): 75-84, 2008

    96 Jungheim, E. S., "Embryos Transfer Practices in the United States: A Survey of Clinics Registered with the Society for ART" 94 (94): 1432-1436, 2010

    97 Tough, S. C., "Effects of IVF on Low Birth Weight, Preterm Delivery, and Multiple Birth" 136 (136): 618-622, 2000

    98 Marcus, A. D., "Dose IVF Cause Birth Defects?; New Research Suggests Links Between Fertility Treatments And Some Health Problems"

    99 Kapiteijn, K., "Does Subfertility Explain the Risk of Poor Perinatal Outcome after IVF and Ovarian Hyperstimulation?" 21 (21): 3228-3234, 2006

    100 Kremer, J. A. M., "Does ICSI Lead to a Rise in the Frequency of Microdeletions of the AZFc Region of the Y chromosome in Futrue Generation?" 13 (13): 2808-2811, 1998

    101 IHE (Institute of Health Economics), "Determinants and Prevention of Low Birth Weight: A Synopsis of the Evidence" Alerta 2008

    102 Bergh, T., "Deliveries and Children Born After IVF in Sweden 1982-95: ARetrospective Cohort Study" 354 (354): 1579-1585, 1999

    103 Tournaye, H., "Declining Clinical Andrology: Fact or Fiction?" 12 (12): 876-879, 1997

    104 Bhattacharya, S., "Conventional IVF versus ICSI for the Treatment of Non-Male- Factor Infertility: A Randomised Controlled Trial" 357 (357): 2075-2079, 2001

    105 Lancaster, P. A. L., "Congenital Malformations after IVF" II (II): 1392-1393, 1987

    106 te Velde, E. R., "Concerns about Assisted Reproduction" 351 (351): 1524-1525, 1998

    107 Thorpe, K., "Comparison of Prevalence of Depression in Mothers of Twins and Mothers of Singletons" 302 (302): 875-878, 1991

    108 Human Fertilisation and Embryology Authority, "Code of Practice (Sixth edition)" HFEA 2003

    109 Human Fertilisation and Embryology Authority, "Code of Practice (First Edition)" HFEA 1991

    110 Spallone, P, "Beyond Conception: The New Politics of Reproduction" Macmillan Education Ltd 1989

    111 Kass, L. R., "Babies by Means of IVF: Unethical Experiments on the Unborn?" 285 (285): 1174-1179, 1971

    112 Jequier, A. M., "Attitude to Clinical Andrology: A Time for Change" 12 (12): 875-876, 1997

    113 Department of Reproductive Health and Research, World Health Organization, "Assisted Reproduction in Developing Countries ― Facing Up to the Issues" 63 : 1-8, 2003

    114 Tsirgotis, M., "Assisted Fertilization with ICSI" 62 (62): 781-785, 1994

    115 Saigal, S., "An Overview of Mortality and Sequelae of Preterm Birth from Infancy to Adulthood" 371 (371): 75-84, 2008

    116 Vayena, E., "ARTs in Developing Countries: Are We Caring Yet?" 92 (92): 413-416, 2009

    117 Hansen, M., "ARTs and the Risk of Birth Defects―A Systemic Review" 20 (20): 328-338, 2005

    118 Cook, J. L., "ART-Related Multiple Births: Canada in an International Context" 33 (33): 159-167, 2011

    119 Nyboe Andersen, A., "ART in Europe, 2003" 22 (22): 1513-1525, 2003

    120 The European IVF-Monitoring Programme (EIM), for the European Society of Human Reproduction and Embryology (ESHRE)., "ART in Europe, 2002" 21 (21): 1680-1697, 2006

    121 The European IVF-Monitoring Programme (EIM), for the European Society of Human Reproduction and Embryology (ESHRE)., "ART in Europe, 2001" 20 (20): 1158-1176, 2001

    122 The European IVF-Monitoring Programme (EIM), for the European Society of Human Reproduction and Embryology (ESHRE)., "ART in Europe, 2000" 19 (19): 490-503, 2004

    123 The European IVF-Monitoring Programme (EIM), for the European Society of Human Reproduction and Embryology (ESHRE), "ART in Europe, 1999" 17 (17): 3260-3274, 2002

    124 The European IVF-Monitoring Programme (EIM), for the European Society of Human Reproduction and Embryology (ESHRE), "ART in Europe, 1998" 16 (16): 2459-2471, 2001

    125 The European IVF-Monitoring Programme (EIM), for the European Society of Human Reproduction and Embryology (ESHRE)., "ART in Europe, 1997. Results Generated from European Registers by ESHRE" 16 (16): 384-391, 2001

    126 de Mouzon, J., "ART and IUI in Europe, 2006" 25 (25): 1851-1862, 2006

    127 Nyboe Andersen, A., "ART and IUI in Europe, 2005" 24 (24): 1267-1287, 2005

    128 Nyboe Andersen, A., "ART and IUI in Europe, 2004" 23 (23): 756-771, 2004

    129 Amor, D. J., "A Review of Known Imprinting Syndromes and Their Association with ARTs" 23 (23): 2826-2834, 2008

    130 Schoolcraft, W. B., "A Model for Incorporation of ICSI into a Private Practice IVF Program" 65 (65): 258-261, 1996

    131 보건복지가족부, "2010년 가족건강사업안내"

    132 보건복지가족부, "2009년 모자보건사업안내"

    133 Centers for Disease Control and Prevention, "2009 ART Reports" U.S. Department of Health and Human Services 2011

    134 Centers for Disease Control and Prevention, "2008 ART Reports" U.S. Department of Health and Human Services 2010

    135 Centers for Disease Control and Prevention, "2007 ART Reports" U.S. Department of Health and Human Services 2009

    136 보건복지부, "2006년도 모자보건사업안내"

    137 Centers for Disease Control and Prevention, "2006 ART Reports" U.S. Department of Health and Human Services 2008

    138 Centers for Disease Control and Prevention, "2005 ART Reports" U.S. Department of Health and Human Services 2007

    139 Centers for Disease Control and Prevention, "2003 ART Reports" U.S. Department of Health and Human Services 2005

    140 Centers for Disease Control and Prevention, "2002 ART Reports" U.S. Department of Health and Human Services 2004

    141 Centers for Disease Control and Prevention, "2001 ART Reports" U.S. Department of Health and Human Services 2003

    142 Centers for Disease Control and Prevention, "2000 ART Reports" U.S. Department of Health and Human Services 2002

    143 Centers for Disease Control and Prevention, "1999 ART Reports" U.S. Department of Health and Human Services 2001

    144 Centers for Disease Control and Prevention, "1998 ART Reports" U.S. Department of Health and Human Services 2000

    145 Centers for Disease Control and Prevention, "1997 ART Reports" U.S. Department of Health and Human Services 1999

    146 Centers for Disease Control and Prevention, "1996 ART Success Rates: National Summary and Fertility Clinic Reports" U.S. Department of Health and Human Services 1998

    더보기

    동일학술지(권/호) 다른 논문

    동일학술지 더보기

    더보기

    분석정보

    View

    상세정보조회

    0

    Usage

    원문다운로드

    0

    대출신청

    0

    복사신청

    0

    EDDS신청

    0

    동일 주제 내 활용도 TOP

    더보기

    주제

    연도별 연구동향

    연도별 활용동향

    연관논문

    연구자 네트워크맵

    공동연구자 (7)

    유사연구자 (20) 활용도상위20명

    인용정보 인용지수 설명보기

    학술지 이력

    학술지 이력
    연월일 이력구분 이력상세 등재구분
    2027 평가 재인증평가 신청대상 (재인증)
    2021-01-01 등재 등재학술지 유지 (재인증) KCI등재
    2018-01-01 등재 등재학술지 유지 (등재유지) KCI등재
    2015-01-01 등재 등재학술지 유지 (등재유지) KCI등재
    2011-01-01 등재 등재학술지 유지 (등재유지) KCI등재
    2009-01-01 등재 등재학술지 유지 (등재유지) KCI등재
    2007-01-01 등재 등재학술지 유지 (등재유지) KCI등재
    2004-01-01 등재 등재학술지 선정 (등재후보2차) KCI등재
    2002-01-01 등재 등재후보학술지 선정 (신규평가) KCI등재후보
    더보기

    학술지 인용정보

    학술지 인용정보
    기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
    2016 1.21 1.21 1.32
    KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
    1.4 1.41 1.785 0.11
    더보기
    해외이동버튼